SYK · News · 20261103N
Revenue Performance and Mix
STRYKER CORP · 2026-11-03 · Importance 62 · Surprise 68 · In source text
Stryker reported third-quarter sales of $6.52 billion, below analyst expectations. The quarter was affected by cyberattack pressures, an SAP transition, and supply disruptions. Stryker lowered its full-year 2026 organic sales growth guidance to 6.5%–7.0%; its Orthopaedics division, including hips and knees, grew more slowly than the rest of the company.
Key facts
- Stryker's third-quarter sales were $6.52 billion, below expectations. source
- Stryker's Orthopaedics division, responsible for hip and knee businesses, experienced slower revenue growth than the rest of the company. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | realized | — | Stryker's third-quarter sales were $6.52 billion, below expectations. |